Pfizer-BioNTech vaccine 'highly effective' for 6 months

Thursday, 01. April 2021 13:03

Pfizer Inc. and BioNTech SE announced on Thursday the latest study showed their vaccine against COVID-19 was "highly effective" for six months.

The companies said the jab's success in preventing contagion in the aforementioned period was 91.3%. They also stated the treatment's efficacy in preventing severe disease was 100%, as per the United States Centers for Disease Control and Prevention's (CDC) definition of critical cases, and 95.3%, as per the Food and Drug Administration's (FDA) interpretation. Pfizer and BioNTech added they had not observed any "serious safety concerns."

The latest update on the vaccine's potency comes after a recent study found it was 80% effective after the first dose. Meanwhile, the companies said it was 100% successful in protecting children between the ages of 12 and 15.

Related Links: BioNTech SEPfizer Inc.
Breaking the News / JR